Targeted versus universal decolonization to prevent ICU infection

New England Journal of Medicine

Volumn 368, Issue 24, 2013, Pages 2255-2265

  Huang, Susan S ^a   Septimus, Edward ^b,d   Kleinman, Ken ^e   Moody, Julia ^c   Hickok, Jason ^c   Avery, Taliser R ^e   Lankiewicz, Julie ^e   Gombosev, Adrijana ^a   Terpstra, Leah ^a   Hartford, Fallon ^e   Hayden, Mary K ^f   Jernigan, John A ^h   Weinstein, Robert A ^g   Fraser, Victoria J ⁱ   Haffenreffer, Katherine ^e   Cui, Eric ^a   Kaganov, Rebecca E ^e   Lolans, Karen ^f   Perlin, Jonathan B ^c   Platt, Richard ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Americas Corporation Inc   (United States)

^c Texas A and M Health Science Center ^*

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f RUSH MEDICAL COLLEGE   (United States)

^g John H Stroger Hospital of Cook County   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BATH; BLOODSTREAM INFECTION; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RATE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PRURITUS; RISK REDUCTION; TARGETED DECOLONIZATION; UNIVERSAL DECOLONIZATION;

EID: 84878834991     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1207290     Document Type: Article

References (40)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160-6.
2. Jarvis WR, Jarvis AA, Chinn RY. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2010. Am J Infect Control 2012;40:194-200.
3. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71. (Pubitemid 47598444)
4. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013;34:1-14.
5. Huang SS, Hinrichsen VL, Datta R, et al. Methicillin-resistant Staphylococcus aureus infection and hospitalization in high-risk patients in the year following detection. PLoS One 2011;6(9):e24340.
6. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for Isolation Precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35:Suppl 2:S65-S164. (Pubitemid 350213178)
7. MRSA laws. Washington, DC: Association for Professionals in Infection Control and Epidemiology (http://www.apic.org/Resource-/TinyMceFileManager/ Advocacy-PDFs/MRSA-map.gif).
8. Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007;28:1155-61. (Pubitemid 47580458)
9. Robicsek A, Beaumont JL, Thomson RB, Govindarajan G, Peterson LR. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009;30:623-32.
10. Wenzel RP, Edmond MB. Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis 2010;14:Suppl 4:S3-S5.
11. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533-42.
12. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167:2073-9. (Pubitemid 350036706)
13. Popovich KJ, Hota B, Hayes B, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009;30:959-63.
14. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009;37:1858-65.
15. Platt R, Takvorian SU, Septimus E, et al. Cluster randomized trials in comparative effectiveness research: randomizing hospitals to test methods for prevention of healthcare-associated infections. Med Care 2010;48:Suppl:S52-S57.
16. Perlin JB, Hickok JD, Septimus EJ, Moody JA, Englebright JD, Bracken RM. A bundled approach to reduce methicillin-resistant Staphylococcus aureus infections in a system of community hospitals. J Healthc Qual 2013;35:57-69.
17. Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:Suppl 1:S12-S21.
18. Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines. Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/hicpac/).
19. Solomon MZ, Bonham AC. Ethical oversight of learning health care systems. Hastings Cent Rep 2013;43:Suppl:S1-S44.
20. National Healthcare Safety Network. Patient safety component manual. Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/nhsn/ settings.html).
21. Hayes RH, Moulton LH. Cluster randomized trials. New York: CRC Press, 2009:207.
22. Ripatti S, Palmgren J. Estimation of multivariate frailty models using penalized partial likelihood. Biometrics 2000;56:1016-22.
23. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006;166:306-12. (Pubitemid 43244318)
24. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009;37:85-93.
25. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007;28:249-60. (Pubitemid 46480722)
26. Vital signs: central line-associated blood stream infections - United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011;60:243-8.
27. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419-30.
28. Moody J, Septimus E, Hickok J et al. Infection prevention practices in adult intensive care units in a large community hospital system after implementing strategies to reduce healthcare-associated methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 2013;41:126-30.
29. Nijssen S, Bonten MJ, Weinstein RA. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis 2005;40:405-9. (Pubitemid 40216509)
30. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-6. (Pubitemid 29259335)
31. Upton A, Lang S, Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 2003;51:613-7. (Pubitemid 36336154)
32. Simor AE, Stuart TL, Louie L, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 2007;51:3880-6. (Pubitemid 350057784)
33. Ellis MW, Griffith ME, Dooley DP, et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin- resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother 2007;51:3591-8. (Pubitemid 47519348)
34. Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007;45:541-7. (Pubitemid 47328632)
35. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000;31:1380-5.
36. Fritz SA, Hogan PG, Camins BC, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013;57:559-68.
37. McNeil JC, Hulten KG, Kaplan SL, Mahoney DH, Mason EO. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J 2013;32:124-8.
38. Batra R, Cooper VS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50:210-7.
39. Stickler DJ. Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. J Appl Microbiol 2002;92:Suppl:163S-S70S.
40. The learning health system series. Washington, DC: National Academies Press (http://www.nap.edu/catalog.php?record-id=13301).